These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 32461015)

  • 21. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
    D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
    Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing perioperative and oncological outcomes of transanal and laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of randomized controlled trials and prospective studies.
    Yi X; Zhang X; Li Q; Ouyang J
    Surg Endosc; 2023 Dec; 37(12):9228-9243. PubMed ID: 37872424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Serra-Aracil X; Zarate A; Bargalló J; Gonzalez A; Serracant A; Roura J; Delgado S; Mora-López L;
    Br J Surg; 2023 Jan; 110(2):150-158. PubMed ID: 36224406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transanal total mesorectal excision for patients with rectal cancer : a Systematic review and meta-analysis.
    Ziati J; Souadka A; Benkabbou A; Boutayeb S; Ahmadi B; Amrani L; Mohsine R; Anass Majbar M
    Gulf J Oncolog; 2021 Jan; 1(35):66-76. PubMed ID: 33716215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer.
    Zeng Z; Liu Z; Luo S; Liang Z; Huang L; Ruan L; Chen J; Jie H; Liang W; Liu H; Kang L
    Surg Endosc; 2022 Jun; 36(6):3902-3910. PubMed ID: 34448933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: A case matched study.
    Ye J; Tian Y; Li F; van Oostendorp S; Chai Y; Tuynman J; Tong W
    Eur J Surg Oncol; 2021 May; 47(5):1019-1025. PubMed ID: 33309105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of transanal
    Bhattacharya P; Patel I; Fazili N; Hajibandeh S; Hajibandeh S
    World J Gastrointest Surg; 2022 Dec; 14(12):1397-1410. PubMed ID: 36632123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score-Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision.
    Detering R; Roodbeen SX; van Oostendorp SE; Dekker JT; Sietses C; Bemelman WA; Tanis PJ; Hompes R; Tuynman JB;
    J Am Coll Surg; 2019 Mar; 228(3):235-244.e1. PubMed ID: 30639298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer.
    de Lacy FB; van Laarhoven JJEM; Pena R; Arroyave MC; Bravo R; Cuatrecasas M; Lacy AM
    Surg Endosc; 2018 May; 32(5):2442-2447. PubMed ID: 29101570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
    Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R
    J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035
    [No Abstract]   [Full Text] [Related]  

  • 34. Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.
    Seow W; Dudi-Venkata NN; Bedrikovetski S; Kroon HM; Sammour T
    Tech Coloproctol; 2023 May; 27(5):345-360. PubMed ID: 36508067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hybrid abdominal robotic approach with conventional transanal total mesorectal excision (TaTME) for rectal cancer: feasibility and outcomes from a single institution.
    Nikolic A; Waters PS; Peacock O; Choi CC; Rajkomar A; Heriot AG; Smart P; Warrier S
    J Robot Surg; 2020 Aug; 14(4):633-641. PubMed ID: 31625075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transanal total mesorectal excision (TaTME): current status and future perspectives.
    Vignali A; Elmore U; Milone M; Rosati R
    Updates Surg; 2019 Mar; 71(1):29-37. PubMed ID: 30734896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
    Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ
    Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term oncological outcomes of transanal versus laparoscopic total mesorectal excision for mid-low rectal cancer: a retrospective analysis of 2502 patients.
    Li Z; Liu H; Luo S; Hou Y; Zhou Y; Zheng X; Zhang X; Huang L; Zeng Z; Kang L
    Int J Surg; 2024 Mar; 110(3):1611-1619. PubMed ID: 38091943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of transanal hand-sewn reinforcement in low rectal stapled anastomosis in preventing anastomotic leak after transanal total mesorectal excision].
    Jie HQ; Li Z; Luo SL; Liu ZZ; Zhang XW; Luan L; Liang WF; Hu HX; Kang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jun; 24(6):530-535. PubMed ID: 34148318
    [No Abstract]   [Full Text] [Related]  

  • 40. Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway.
    McLemore EC; Harnsberger CR; Broderick RC; Leland H; Sylla P; Coker AM; Fuchs HF; Jacobsen GR; Sandler B; Attaluri V; Tsay AT; Wexner SD; Talamini MA; Horgan S
    Surg Endosc; 2016 Sep; 30(9):4130-5. PubMed ID: 26659246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.